UPDATE 2-Teva to pay $512 mln to settle claims of delayed generic Provigil
April 20, 2015 at 12:36 PM EDT
April 20 (Reuters) - Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil.